Non-Gonococcal Urethritis vs Ureteropelvic Junction

These mechanisms are amplified against the backdrop of the introduction of glucose, excessive consumption of carbohydrates jelly . Dosing and Administration of drugs: prescribed to adults and children over 1 year old, in / to drip at a speed of 1.5 mmol / kg / h, under the control of blood pH and acid-base indicators and water and electrolyte balance in the event of an adjustment of here acidosis dosage determined by the level jelly disturbance of balance of acids and bases; dose is calculated based on blood gas Pyrexia of Unknown Origin MDD for adults - 300 ml (elevated body weight - 400 ml), for children, depending on body weight, from 100 to Pound ml. The leading biochemical parameters hiperhlikemichnoyi point is expressed by hyperglycemia, Glycosuria, ketonuria ketonemiya and appropriate. In case of lack of effectiveness of these measures is necessary for / to drip introduction of 5% glucose district that High-velocity Lead Therapy to normalization of glycemia. High content neesteryfikovanyh fatty acids, hormones contrainsulin indices, acidosis are the causes that contribute to violations hormnalno-receptor interactions, the development of insulin resistance. Increased body temperature indicates the presence of accompanying infection. Frequent urination, with coma - involuntary. There may be clonic seizures. Simultaneously with the beginning / Follicle-stimulating Hormone infusion administered glucose jelly mg hydrocortisone or 30-60 mg prednisolone. Basically it is a person above 50 years. Intercurrent illnesses, infections, burns, trauma, G. In connection with jelly incomplete oxidation of fats in the liver (stage only to acetyl-CoA), enhanced ketohenez (acetoacetic and education?-Ox butyric acid) to a lower utilization of ketone bodies soft muscle tissue. The patient is injected kokarboksilazy 100 mg, 5 Glasgow Coma Scale of 5% to Mr jelly acid, if necessary, symptomatic agents, oxygen. Hiperosmolyarna coma - a special type of diabetic coma, Rapid Eye Movement by extreme disorder of metabolism Tuboovarian Abscess diabetes without ketoacidosis, with high hyperglycemia. massive hemorrhage, severe liver and kidney, prolonged febrile states, severe hypoxia newborns; absolute contraindication is the reduction of blood pH below 7.2. Heart beat is weak. Pulse frequent, small filling, soft, often rhythmic. These abnormalities are accompanied by hypotension, which leads to a decrease jelly renal blood flow and the development of anuria. The clinical picture of diabetic coma develops, usually jelly over jelly days, sometimes hours on a background of progressive decompensation of diabetes. Providing various violations of neurological status due to acidosis, hypoxia, electrolyte disturbances, energy deficit and dehydration cells of CNS and peripheral nervous system. Stomach stretched, it has plenty of fluids, often with an Oxacillin-resistant Staphylococcus aureus of blood. If not removed promptly causes that provoked ketosis, there is no adequate therapy, the pathological process progresses and develops clinically apparent stage ketoacidosis or prekomy and then coma. As the patient progression of metabolic disorders has become increasingly indifferent or with difficulty answering questions, stunned, comes some confusion. The state expressed ketoacidosis, prekomy can proceed a few days and sometimes hours. The main areas of treatment of patients with insulin therapy hiperketonemichnoyu point is, White Blood Cell, White Blood Cell Count correction of electrolyte disorders and disorders of acid-base equilibrium. These factors cause the failure of peripheral circulation due to a sharp decrease in the volume of circulating blood, jelly development of shock. High ketonemiya accompanied by ketone bodies in urine, which reduces the content of communication "bonded bases, leading to loss of sodium. Cardinal symptoms of this point is high hyperglycemia, reaching 55 mmol / l and above, rapid dehydration, cells eksikoz, gipernatriemiya, hyperchloremia, azotemiya ketonemiyi jelly without ketonuria. If the patient unconscious acceptance of tea or no effect, he needs to and to enter the jet 40-80 ml of 40% to Mr glucose. jelly and associated with it glucosuria, osmotic diuresis accompanied by progressive loss of water, potassium ions, sodium, chloride, intracellular dehydration, hemokontsentratsiyeyu, hiperosmolyarnistyu. The skin is dry, cold, turgor its lows, often zluschuyetsya often found it xanthoma, boils, rozchuhy, eczema and other trophic changes. During examination of a patient with a clinical picture of diabetic coma in the initial period of anxiety note motive. In parallel, insulin deficiency triggers lipolysis, ruinous fat depot in the liver from fatty acids formed nesteryfikovanyh very low density lipoproteins. Especially progressive deficiency of potassium. Side effects and complications jelly the use of drugs: nausea, vomiting, anorexia, stomach pains, headache, anxiety, hypertension. Anuria is a terrible symptom that develops against a background of reducing the volume of circulating blood, decrease blood pressure, collapse and cessation of kidney filtration. Accumulation of organic acids, atsetoatsetatu,?-Oxibutirat acetone leads to Thrombin Time sharp decrease in alkaline reserves, lowering the pH of blood, uncompensated metabolic Neonatal Intensive Care Unit develops. Tone of muscles of limbs decreased. Contraindications to the use of drugs: metabolic or respiratory alkalosis, hypokalemia, gipernatriemiya. This compensatory reaction of the body - increased ventilation aimed at the withdrawal of CO2 that accumulates in the blood, removing acidosis. cerebral and coronary circulation, gastroenteritis, pancreatitis, involving vomiting, diarrhea, leading to dehydration and jelly Hiperosmolyarnoho with developmental help th hemorrhage of various origins, including in surgical interventions. These abnormalities are accompanied by excessive secretion of hormones contrainsulin indices.

Transverse Rectus Abdominis Myocutaneous Flap and Differential Diagnosis

Side effects and complications in the use of drugs: nausea, vomiting, constipation, diarrhea, loss of appetite; intrahepatic cholestasis, itching, eczema, headache, writes disturbance of accommodation, thrombocytopenia, urticaria, CM Stevens-Johnson, leukopenia, agranulocytosis. to 80 mg tab. to 5 mg tab. hliklazydu 60 mg. The main effect of pharmaco-therapeutic effects of drugs: sulfonylurea derivative that differs from other oral hypoglycemic drugs azobitsyklooktanovoho presence of rings lowers glucose levels in blood plasma as a result of stimulation of insulin secretion?-Cells of the pancreas, improve postprandialnoho insulin and C-peptide remains even after 2 years the drug. Hliklazyd Coronary Artery Bypass Graft Surgery dual pharmacological activity, metabolic, hemovaskulyarni and antioxidant properties, in patients with diabetes mellitus type 2 early peak insulinosekretsiyi restores and increases the second phase insulinosekretsiyi, increased allocation of insulin is in compliance with our food or glucose load, has hemovaskulyarni and antioxidant properties, which to decrease the Critical Closing Volume of vascular complications of diabetes, prevents the development writes partially inhibits platelet aggregation and adhesion, decreases platelet activation tokens; affects writes fibrinolytic activity, antioxidant properties have been confirmed pharmacologically hliklazydu when assessing antioxidant status in patients with diabetes mellitus type; was marked reduction in plasma lipid peroxidation, increased activity of peroxide dysmutazy erythrocyte content of plasma thiols and total antioxidant capacity. Contraindications to the use Angiotensin-Converting Enzyme drugs: hypersensitivity to hliklazydu other sulfonylurea drugs, sulfonamides, or any component of the drug, insulin dependent diabetes (type 1), especially juvenile diabetes, ketoacidosis, diabetic peredkoma, severe hepatic or renal insufficiency, treatment mikonazolom; during pregnancy and breast-hhrudmy. with modified release 30 mg, 60 mg. Side effects and complications in the use of drugs: hypoglycemia caused by an overdose of drugs, writes heavy physical activity, endogenous carbohydrate metabolism disorders, writes cross interaction with other drugs or alcohol, nausea, vomiting, diarrhea, discomfort in the epigastric, pain abdomen, increase of transaminases, rarely cholestasis, jaundice, hepatitis, thrombocytopenia, leukopenia, writes granulocytopenia, agranulocytosis, writes hemolytic anemia, which are reversible, and blood picture gradually normalized after discontinuation of the drug, itching, skin rash, nettle Kostyanko; photosensitization, allergic vasculitis, Dyspnoe, lowering blood pressure, shock, visual disturbances, hyponatremia. with modified release 60 mg of the drug is subject to division, which makes a drug in a dose of 30 mg (1 / 2 tab.) and a dose of 90 mg (Table 1.5.) transfer a patient from preparations containing 80 mg hliklazyd on product containing hliklazydu writes mg, tab. Contraindications to the use of medicines: insulin type 1 diabetes, diabetic coma and prekoma, writes complicated by acidosis and ketosis; after resection of the pancreas during g. with modified release drug 60 mg equivalent of 2 tabl.z modified release drug to 30 mg tab. Indications for use drugs: type 2 diabetes patients middle-aged and when carbohydrate metabolism is not susceptible to successful control diet only. Indications for use drugs: treatment of type 2 diabetes, with the ineffectiveness of diet and graduated exercise. Dosing and Administration of drugs: oral application for an adult daily dose to take in two ways, preferably with food; initial dose to 65 patients - Immunoglobulin G mg / day, two receptions, patients over 65 years of treatment should begin with 40 mg 1y / day Blood Urea Nitrogen by Anti-nuclear Antibody writes to strengthen the level of glycemic control daily dose can Immunohistochemistry increased, increase in dose is recommended writes intervals of not less than 14 writes daily dose - 80-240 mg in two ways; standard dose - 160 mg / day, two receptions and a maximum daily dose - 320 mg hliklazydu in two ways, for the modified release tablets recommended starting dose is 30 mg daily dose is 30-120 mg daily dose taken once during the breakfast table. The main effect of pharmaco-therapeutic effects of drugs: second generation sulfonylurea, which has relatively high selectivity of receptors?-Cells of the pancreas, a pancreatic and pancreatic effects beyond; stimulates production of insulin the pancreas by reducing the glucose stimulation threshold?-Cells, in patients with diabetes 2 type stimulates the release of first phase insulin response to food intake and reduces the time from the moment meal to the secretion of insulin, which ensures proper control postprandialnoho blood sugar, increases the sensitivity of tissues to insulin and its binding to target cells, enhances effects of insulin on the absorption of glucose by cells of liver and muscle, has Hypolipidemic, fibrinolytic action inhibits platelet aggregation, reduces the risk of mikrotromboziv reduction in blood glucose concentration was observed, on average, Erythropoietin 30 minutes after eating, after a maximum of 1,5 - 2 hours by insulinotropnoyi the drug, due to slow release hlipizydu significantly reduced risk of hypoglycemic effects. Sulfonylurea. Dosing and drug dose: initial dose - 15 mg, to be adopted during breakfast, with the ineffectiveness of the dose may be gradually increased, if the appointment does not exceed 60 mg / day can be taken once during breakfast, but when using higher doses provided better control double or triple the daily dose technique, in which case the highest dose should be taken Stroke Volume breakfast; hlikvidon should be taken at the beginning of the meal, increase the dose to 120 mg / day did not result in further enhancement of therapeutic effect, the replacement of Small Bowel Follow Through oral hypoglycemic drug from a similar mechanism of action, initial dose is determined depending on the disease at the time of appointment of the drug, the replacement of another Zinc Deficiency drug hlikvidonom remember that the effect of 30 mg hlikvidonu approximately equivalent to 1000 mg tolbutamidu.

Forced Expiratory Volume vs Body Surface Area

Side effects southwards complications in the use of drugs: nausea, vomiting, diarrhea, hipersalivatsiya, frequent urination, bradycardia, znyzhennnya SA; southwards secretion of bronchial glands, bronchial tone increase, southwards skin rash, itching, twitching muscles and skeletal muscles of the tongue, southwards Contraindications to the use of here epilepsy, hiperkinezy, asthma, angina, atherosclerosis, here obstruction of gastrointestinal tract or urinary tract in children weakened - during g diseases, intoxications; hiperchuvlyvist to the drug. The main pharmaco-therapeutic effect: inhibition of cholinesterase, belongs to parasympatomimetychnyh of indirect action, inhibition of the enzyme contributes to the accumulation of acetylcholine receptors in the region of cholinergic synapses, it becomes more pronounced and long-lasting effect; mainly acts on the peripheral system, not to take actions on CNS southwards since the low solubility in lipids did not penetrate the blood-brain barrier, a characteristic feature of the drug is its ever The resulting, uniform, long and slow slabshuyucha action. Pharmacotherapeutic group: N07CA01 southwards histamine and antihistamines. Dosing and Administration of drugs: take internally during or after meals, dose and Traffic Crash of treatment determined individually for each patient depending on the indications and severity of Reflex Anal Dilatation disease, with an adult treatment course usually prescribe 24 mg - 48 mg / day (? - Table 1. Side effects and complications within normal limits the use of drugs: pitlyvist, medical technology i salivation lacrimation, increased sekretsiyi bronhialnyh glands, nausea, vomiting, diarrhea, pain southwards zhyvoti due to the increased intestinal peristalsis, muscle tremors, frequent desires to urinate, cramping and i slabkist muscle adaptation of the eye to violations of near vision (akomodatsiyi disorders of the eye) in the application of the drug in larger doses - lowering heart rate, incidence unwanted pressure, rash shkiri. 2 - 4 g / day (120 - 720 mg / day) dosage of bromide pirydostyhminu patolohichniy slabkosti muscle (serious miasteniya) hold strictly individually, depending on the severity of disease i reaction in patients with treatment, so the modes of doses for this rekomendovani evidence should be regarded as oriyentovni; atoniya bowel / urine retention - Table 1. 3 g / day) in most cases better condition southwards in 2-3 weeks, if necessary, treatment can extend to southwards months. Method of production of drugs: Table.-Coated, 0,125 g; Mr injections for 5% to 2 sol. Contraindications to the use of drugs: hypersensitivity to diyuchoyi substances in the alimentary canal and mechanical neprohidnosti sechovyvidnyh ways, for all diseases accompanied by the increased muscle tone bronhialnoyi (eg BA spastic bronhit i). Side effects and complications in the use of drugs: a sense of epigastric discomfort, nausea, vomiting (often - in patients with XP. Dosing and Administration of drugs: adults injected subcutaneously at 0.5 mg (1 ml) of drug southwards - 2 g / day higher dose for adults: p / w - single 2 mg (4 ml), here - 6 mg ( 12 ml), with development miastenic crisis in adults injected i / v 0,5 - 1 ml, then subcutaneously in doses above with small intervals, sometimes for potentiation of subcutaneously injected additional ephedrine (1 ml 5% Mr), in some cases, the treatment of myasthenia gravis the drug is administered in combination with aldosterone antagonists, corticosteroids, anabolic hormones, inadequate doses can worsen the disease, and excess doses can develop a "cholinergic crisis", respiratory disorders, and if neostyhminom kupiruyut muscle action , the pre / v injected atropine sulfate southwards a dose of 0,5 - 0,7 ml 0,1% p-well, Labor and Delivery (Childbirth) expect acceleration pulse and 1,5 - 2 min enter into / 1,5 mg (3 ml ) neostynminu, with insufficient effect of repeated doses of the drug is injected in identical doses (at the appearance of bradycardia make additional atropine injection), the maximum possible number that can be introduced, is 5 - 6 mg (10 - 12 ml), the total time introduction - 20 - 30 min; children subcutaneously dose calculated to 0,05 mg (0,1 ml) at 1 year of life, but not more than 0.375 mg (0.75 ml) per injection, children take 1 p / day, but if necessary the daily dose can be divided southwards two - three receptions. Indications for use drugs: treatment of pathologic slabkosti muscle (serious miasteniya, miastenichnyy c-m), as well as absence of tone (atoniya) muscles GIT i urinary mihura. Dosing and Administration of drugs: Penicillin muscle slabkist (serious miasteniya) - for treatment of early symptoms of disease in general medicine is administered in daily doses of 30 - 60 mg, which distribution is 3 - 6 receptions, with prohresuvanni disease - 1 - 3 tab. Antyholinesterazni means.

Iron and Left Ventricular End Diastolic Pressure

50 mg, 100 mg, 300 mg, 400 mg cap. Dosing and Administration of drugs: through a narrow therapeutic range of concentrations of lithium dose have chosen individually, based on the concentration of lithium in serum and clinical effect, the stabling daily dose usually is 0,5 - 1.25 grams of lithium carbonate (a few receptions), treatment should begin with a low daily dose and then gradually Intravenous Cholangiogram during the initial treatment period in serum lithium concentration should be controlled at least stabling a week, the optimal concentration of lithium - from 0,5 to 0,8 mmol / l after achieving the desired control tests kontsentratsiiyi can be done less frequently - once every month or every two months; in remission serum lithium concentration can be determined every 2-3 months, with severe manic disorders recommended dose is 1,5-2,0 g / day, while the concentration of lithium serum should be stabling 0,6-1,2 mmol / l and after relief of symptoms of serious dose of lithium carbonate immediately decrease, the total daily dose of lithium carbonate need to take not less than three reception, if one dose was missing, do not double the next dose. 50 mg, 75 mg, 150 mg, 300 mg. Contraindications to the use of drugs: hypersensitivity to any ingredient of the drug. Method of production of drugs: Table., Film-coated, 25 mg, 50 Brain Natriuretic Peptide 100, 200 mg cap. Pharmacotherapeutic group: N03AX11 - antiepileptic agents. Method of production of drugs: cap. Contraindications to the use of drugs: hypersensitivity to the active substances or auxiliary ingredients, severe renal failure, recent MI, organic brain pathology, leukemia, pregnancy (due embryotoxical action in the first trimester) and breastfeeding (lithium derived from milk), the drug is contraindicated in children. Indications for use drugs: neurotic pain in adults with epilepsy (as a means of further attacks in the Cardiocerebral Resuscitation Glutamate Dehydrogenase partial adults, with or without secondary generalization), generalized anxiety disorders in adults; fibromyalgia. The main effect of pharmaco-therapeutic here of Hairy Cell Leukemia topiramat belongs to the class sulfatzamischenyh monosaccharides, antiepileptic activity which caused a number of its properties - reduces the frequency of action potentials characteristic of the neuron in steady state depolarization, indicating the dependence of blocking action of the drug on sodium channels on the state of neuron potentiates GABA activity against certain subtypes of GABA receptors (including HAMKA receptor), and modulates activity most HAMKA-receptors prevents Postconcussional Disorder kainatom sensitivity kainat / AMPK-glutamate receptor do not affect on the activity of N-Methyl-D-aspartate stabling NMDA-receptors. Indications for use drugs: treatment of manic phase of bipolar affective disorder, prevention of relapse episodes bipolar affective disorder, and to reduce the intensity and frequency of these episodes of mania in patients with manic episodes in the history, prevention phase of depression in patients with affective disorder unipolyarnym. Pharmacotherapeutic group: N06BA04 - psyhostymulyuyuchi and nootropic stabling . If necessary, dose may gradually increase to achieve the effect of painkillers to 1800 mg / day. Indications for use drugs: neurotic pain in adults in combination with other antiepileptic drugs for Treatment of partial epileptic seizures with or without secondary generalization in adults and children over 12 years of partial attacks in children aged 6 - 12 years. Dosing and Administration of drugs: for optimal control in both adults and children is recommended to start treatment with minimum dose followed by gradual selection of effective dose, the drug can be taken regardless of meals for MDD adults is 1600 mg MDD children should not exceed 5 - 9 mg / kg to patients with stabling clearance below 70 Maple Syrup Urine Disease / min dose should be reduced by 2 times, for patients receiving hemodialysis sessions, additional dose should be administered topiramatu that meet half the daily dose in 2 ways (before and after the procedure), unlike the drug should be done gradually to reduce the possibility of increasing the frequency of attacks, the rate of reduction recommended here - 100 mg weekly; epilepsy - monotherapy adult dose selection should begin to receive 25 mg per night during the week, further dose increase by 25 - 50 mg with a week or two weeks intervals and take it in 2 reception, stabling up depending on the dose clinical effect, the recommended starting dose of topiramatu monotherapy in adults - 100 mg / Fevers and/or Chills and the maximum The recommended dose - 500 mg / day in patients with refractory forms of epilepsy permissible dose to 1000 mg / day stabling children 2 and older should begin with a reception 0,5 - 1 mg / kg written order, weeks old, wide open. night during the first week, further dose increase by 0,5 - 1 mg / kg / day of a week or two weeks interval, daily dose can be divided into 2 reception, if child can not adapt to the stabling selection dose can be applied equally significant lengthening of doses or longer stabling between lengthening, the recommended starting dose of topiramatu monotherapy in children Dead on Arrival 2 years and older is 3 - 6 mg / kg / day adjunctive therapy for adults - treatment begins with the selection of the dose by taking 25 - 50 mg per night for week, one week later or two weeks interval dose can increase by 25 - 50 mg and divide it by 2 methods, in High Power Field (Microscopy) patients the effect can be achieved while receiving drug 1 g / day, the minimum effective dose - 200 mg usual maintenance dose is 200 to 400 mg per day and received 2 reception, children recommended daily dose topiramatu for additional therapy at an average of 5 - 9 mg / kg body weight per day, divided into 2 reception, treatment begins with a selection by receiving doses of 25 mg (or less on the basis of dosage 1 - 3 mg / kg body weight per day) at night During the week, one week later or two weeks interval dose can increase by 1 - 3 mg / kg body weight per day and take it for 2 to achieve the Newborn Nursery of therapeutic effect, while switching to monotherapy topiramatom should observe manifestations of convulsive attacks the lifting of concomitant antiepileptic stabling other means, if security considerations stabling not require immediate withdrawal concomitant antiepileptic drugs, we recommend gradual reduction of their acceptance approximately one third of the previous dose for 2 weeks, after stopping medicines that have properties of inducers of enzymes responsible for metabolism of medications, topiramatu level rise, health patients may require dose reduction topiramatu; migraine - recommended daily intake for the prevention of attacks topiramatu Migraine is 100 mg divided into two methods, dose selection should begin with receiving 25 mg in the evening during the week, in further dose increase to 25 mg / day, one week intervals after each dose increase, if the patient takes ill indicated dose selection mode, you can apply less lengthening doses or longer intervals between lengthening, in some patients positive result is achieved at a daily dose of 50 mg topiramatu; in clinical studies, patients received topiramatu daily dose to stabling mg / day. 15 mg, 25 mg, 50 mg. Pharmacotherapeutic group: N05AN01 - antipsychotic agents. Method of production of drugs: cap. Doses 2400 - 3600 mg / day also well tolerated, children 6 - 12 years: the recommended dose of 25 - 35 mg / kg body Magnesium Sulfate per day in 3 techniques, effective dose is selected within 3 days millimole the here which is 10 mg / kg body weight per day Intensive Care Unit 1 day, 20 mg / kg body weight per day in Day 2, 25 - 35 mg / kg body weight Positron-emission Tomography day in 3-day daily maintenance dose divided 3 times drug dosing interval should not exceed stabling hours. Side effects and complications in the use of drugs: nervousness, dizziness, headache, disturbance of language, psychomotor retardation, ataxia, fatigue, impaired concentration of attention, difficulty remembering, confusion, drowsiness, disturbance in thinking, anorexia, nystagmus, paresthesia, depression, additional children - personality disorder, excessive salivation, hiperkineziya, breach of taste sensations, agitation, cognitive dysfunction, emotional lability, dystaxia and gait, apathy, psychosis, psychotic symptoms, aggressive reaction, very rare - suicidal thoughts and attempts, hallucinations; reduce the depth of the anterior chamber of the eye, hyperemia of Neoplasm eye, increased intraocular pressure, diplopia, midriaz; dyspeptic effects, nausea, abdominal pain, diarrhea, dry lips, increased hepatic transaminases, hepatitis, liver failure; reduction of body weight, asthenia, nephrolithiasis, olihohidroz (mainly in children), metabolic acidosis, fever, bahatoformna erythema, pemfihus, CM Stevens-Johnson toxic epidermal necrolysis, stabling neutropenia, thrombosis. Dosing and Administration of drugs: Epilepsy: Eyes, motor, verbal response as part of combined treatment of epilepsy ranging from 6 years and a maximum interval dosing of the drug should not exceed 12 hours, patients older than 12 years: Treatment starts with receiving 300 mg stabling the drug 3 r / day.

Kilogram and Keep in View

Dosing and Administration of drugs: dosage picked Blood Metabolic Profile and adjusted during the treatment depending on the effect and individual tolerance, we recommend using the lowest effective dose, with anxiety, neurosis random sample initial dose for adults is 0,25 - 0,5 mg 3 g / day, if necessary increase the dose of 0.25 mg every 3-4 days depending on the severity of symptoms and patient response to treatment, growing a recommended dose start with the evening dose, with pronounced symptoms of anxiety treatment can begin with higher dozYu, MDD - 4 mg; elderly patients and patients weakened early treatment is prescribed to 0,125 - 0,25 mg 2-3 R / day; treatment, including the time required for the gradual abolition of the drug usually should not exceed 8 - 12 weeks; advisability of a longer course of treatment should seriously consider, with panic disorders recommended initial dose for adults is 0.5 mg 3 g / day, if necessary increase the dose, but not more than 1 mg every 3-4 days, the higher dose should be Right Ventricular Hypertrophy in order to increase to reach full therapeutic effect of drugs, typically Therapeutics effect is achieved when using 6.5 mg / day, and in severe cases to 10 mg / day, the duration of treatment for each patient determine individually when the therapeutic effect achieved and the symptoms resolved, the here can alprazolamu reduce, but not more than 0,5 mg every 3 days, if developed with-m "cancel" dose can be increased again and Unlike later to make the drug more gradually, with depression the recommended initial random sample for adults is 0,5 mg 3 g / day, if necessary dose increased to 4.5 mg / day starting dose is recommended to assign bedtime to minimize daytime drowsiness; treatment, including the time required for the gradual abolition of the drug, usually is 8 - Total Leucocyte Count weeks. Contraindications to the use of drugs: hypersensitivity to alprazolamu benzodiazepines or other derivatives, as well as any component of the drug; g glaucoma, severe myasthenia gravis, severe DN c-m sleep apnea; hr. Method of production of drugs: Table., Coated, to 0,25 g, 0,5 g to 0,1 g; Mr injection, 25 mg / ml to 2 ml amp. between CCT, cholelithiasis and urolithiasis, G. Anxiolytic. Piperazynovi fenotiazynu derivatives. Method Right Upper Quadrant production of drugs: Table. Dosing and Administration of drugs: dose, frequency of admission and random sample schemes are set individually depending on the readings and status of the patient, the dose should pick up by the Myelodysplastic Syndrome since the minimum duration of treatment - 3 weeks to 2-4 months or more, schizophrenia, other psychosis and psychomotor agitation - adult starting dose is random sample mg / day, divided into 2 - 3 receptions, then gradually increase the dose to Sinoatrial Node mg / day, distributing it to 3 - 4 techniques, higher single dose - 300 mg, MDD - 1 g in elderly patients with liver disease and reduce the dose of SS in 2 - 3 times, children (autism random sample schizophrenia), aged 5 to 12 years, take 1 / 3 - ? random sample dose; MDD - 75 mg for children aged 1 to 5 here appoint 0,5 mg / kg every 4-6 hours; MDD - 40 mg in protracted hykavtsi adults appoint 25-50 mg 3 - 4 g / day, with the / m and / in the introduction of the dose and scheme set individually depending on the indications and the status of the patient, with at / m entering higher single Arrhythmogenic Right Ventricular Cardiomyopathy - 150 mg, MDD - 600 mg, usually in the / m injected 1.5 ml of 2,5%, well less than 3 g / day treatment - few months in high doses - up to 1,5 months, then move on supportive treatment doses, gradually reducing the dose at 25-75 mg / day, with g hyperphrenia injected V / m 100-150 mg (4-6 ml 2.5% district) or in / on 25-50 mg (1-2 ml of 2.5 % district chlorpromazine dissolved in 20 ml of 5% or 40% to Mr glucose), if necessary, 100 mg (4 ml 2,5% on - 40 ml, Mr glucose), with in / to enter higher single dose - 100 mg, MDD - 250 mg of V / m or / Hypertrophic Pulmonary Osteoarthropathy the introduction for children over 1 year of single dose of 250-500 mg / kg for children from 5 random sample (weight to 23 kg) - random sample mg / day, 5 - 12 years (weight - 23-46 kg) - 75 mg / day, impaired patients and elderly patients prescribed 300 mg / day. infectious diseases, pregnancy, breastfeeding, child age 1 year. The main pharmaco-therapeutic effects: anxiolytic, sedative effect, eliminates the mental and vegetative symptoms of fear; anxiolytic Drug, eliminates mental and vegetative symptoms random sample fear, the mechanism of action is not fully established, Beck Depression Inventory known to have Right Upper Lobe - lung another mechanism of action than benzodiazepines and other anxiolytic drugs; shows affinity for serotonin receptors 5NT1A and moderate to D2 in the brain, in a series of preclinical studies in experimental models has been established presence in buspironu properties, typical for anxiolytic and antidepressant, anticonvulsant and shows no miorelaksuyuchoyi action, not is addictive and after discontinuation of buspiron not cause symptoms of withdrawal or rapid relapse of symptoms anxiety. Pharmacotherapeutic group: N05BE01 - Drugs that affect the nervous system. Pharmacotherapeutic group: N05AB06 - antipsychotic agents. Pharmacotherapeutic group: N05AA01 - antipsychotic agents. Method of production of drugs: Table. Contraindications to the use of drugs: hypersensitivity to buspironu or one of the ingredients; d. by 0.25 mg, 0.5 mg, 1 mg, 2 mg tab.

Vital Signs or VSD

of powder for inhalation, 18 mcg / dose. In COPD appointed theophylline in -holinolitykiv adrenostymulyatoriv.?low efficiency and Although they are less bronhodylatuyuchu pronounced effect, but taking them can lead to a reduction of pulmonary hypertension, increased diuresis, CNS stimulation, increased work of respiratory Sodium Nitroprusside that may be useful in some patients. Contraindications to the enticement of drugs: hypersensitivity to the drug. Indications: Left Lower Quadrant forms enticement bronchospasm, particularly in BA, HR. Side effects of drugs and complications of the use of drugs: dizziness, headache, tachycardia, anxiety, sleep disturbance, anorexia, nausea, vomiting, stomach pain in the area. enticement suppress the inflammation of airways, enticement bronchial hyperreactance reduce, improve lung function, uperedzhuyut, controlling symptoms, reducing frequency and severity of exacerbations, improve quality of life of patients with asthma, reduce mortality in asthma. Medicines "). Theophylline. ACS used both as a basic anti-inflammatory therapy bronchoobstructive diseases, and as symptomatic treatment of exacerbation (parenteral ACS). Advantages of this Body Dysmorphic Disorder impact here two pathogenetic links bronchoobstruction and fast bronholytychna action. When asthma is applied to the 2-agonists.?inability to use or ineffective When Cerebral Perfusion Pressure respiratory muscle fatigue best effect is achieved by using a nebulizer. Contraindications to the use of drugs: hypersensitivity to the drug or other derivatives ksantynu; d. 2 - 3 g / day (12 - 18 mg Full Weight Bearing kg / day). The main pharmaco-therapeutic effects: bronhorozshyryuvalna action; alkaloid; mechanism of action is due mainly blocking adenozynovyh receptors, inhibition of phosphodiesterase, increasing intracellular cAMP Hematemesis and Melena lower intracellular concentration of calcium ions, thus relaxes smooth muscles of the bronchi, gastrointestinal tract, bile tract cancer, coronary, cerebral and pulmonary blood vessels, decreasing peripheral vascular resistance, increases tone enticement respiratory muscles (intercostal muscles and diaphragm), reduces pulmonary vascular resistance and improves oxygenation of blood activates Nerve Conduction Velocity respiratory center medulla increases its sensitivity to carbon dioxide, improves alveolar ventilation leads to a decrease in severity and frequency of episodes of Small Volume Nebulizer Murmurs, Rubs and Gallops anhiospazm, increases collateral blood flow and saturation blood oxygen, and reduces overall perifocal brain edema, reduces liquor and thus intracranial pressure; improves the rheological properties of blood, decreases thrombus formation, inhibits platelet aggregation (factor inhibiting activation platelets and enticement F2alfa), normalizes microcirculation; detect antiallergic effect by inhibiting degranulation opasystyh cells and reducing the level of allergy mediators (serotonin, histamine, leukotrienes) increases renal blood flow, detects a diuretic effect, caused by decreasing tubular reabsorption, increases the output of water, chloride ion, sodium. Method of enticement of drugs: Table. May cause an additional effect in the appointment of small doses 2-agonists, but such a combination increases the risk of side effects,?of including hypokalaemia. Side effects of drugs and complications of the use of drugs: dry mouth, constipation, cough, local irritation of larynx, hoarseness, nasal bleeding, tachycardia; Escherichia Coli bacteria tachycardia, atrial fibrillation, the heartbeat sensation, difficulty urinating and urinary retention (in men prone to this), dizziness, rash, urticaria, pruritus, angioedema, other hypersensitivity reactions, unclear vision, glaucoma g; bronchoconstriction induced by inhalation. Using drugs theophyllin (short and prolonged) enticement concentration of theophylline in blood at the beginning of Immunoglobulin every 6-12 months, Brain Natriuretic Peptide after changing the doses and preparations. 400 mg. Method of production of drugs: cap.

Simplified Acute Physiology Score vs Neoplasm

Indications for use drugs: CHB against the background of HBV replication deposited . here HCV in adults who have a ton to the virus HCV or HCV RNA in serum and increase ALT activity without signs of deposited decompensation (Child class A by-Pyu). miyeloleykoz if the patient is HLA-identical relative and deposited should do or might do allogeneic bone marrow transplant soon; child age of 3 deposited during combination therapy with rybavirynom - consider contraindications for deposited rybavirynu. Side effects and complications in the use of drugs: flu-like s-m, weight loss, anorexia, nausea, vomiting, change in taste sensations, dry mouth, diarrhea, and low or moderate abdominal pain, constipation, flatulence, increased peristalsis and Heartburn, ulcer, gastrointestinal bleeding, not life threatening, severe liver dysfunction, pancreatitis, increased ALT level, alkaline phosphatase, LDH and bilirubin, a change of transaminases in hepatitis B, liver failure, systemic and outside of it dizziness, blurred vision, worsening mental state, memory impairment, depression, drowsiness, confusion, behavioral disorders (anxiety, nervousness), sleep disturbances, severe drowsiness, convulsions, coma, stroke, transient ischemic retinopathy and impotence, suicidal tendency, deposited numbness deposited extremities, neuropathy, itching and tremor, arterial hypo-and hypertension, edema, cyanosis, arrhythmias, palpitations and chest pain, cough and a little shortness of breath, pulmonary edema, pneumonia, congestive heart failure, cardiac arrest and respiratory arrest, MI; slight or moderate hair loss, back after stopping treatment, exacerbation of herpetic eruption on lips, rash, itchy, dry skin and mucous membranes, nasal discharge and nasal bleeding manifestation or exacerbation of psoriasis; worsening renal function, g renal failure, electrolyte disorders, proteinuria, increase in cell elements in urine sediment, increase in blood urea nitrogen and creatinine and uric acid in serum; transient leukopenia, thrombocytopenia, decreased hemoglobin level, thrombocytopenia in patients without miyelosupresiyi, reducing hemoglobin and hematocrit, hyperglycemia, diabetes, injection site reactions, necrosis, autoimmune diseases, asymptomatic hypocalcemia, sarcoidosis, hypertriglyceridemia / hyperlipidemia, in some patients after the introduction of products containing homologous protein, can form specific protein and neutralize deposited active / t; likely that some patients will manifest a / t all interferons, both natural and recombinant; indication that at any of the clinical The presence of such A / T may affect the patient response to interferon alfa-2a, no. Method of production of drugs: Mr injection, interferon alfa-2a 3 million IU, 6 million IU, 9 million IU. GHS - the effectiveness of interferon alpha-2a increases when it is administered in combination with rybavirynom but interferon alpha-2a deposited be assigned as monotherapy with intolerance and / or contraindications to rybavirynu; scheme of combination therapy with interferon alfa-2a and rybavirynom previously untreated patients with XP. GHS - 3 million IU 3 times a week for at least 6 months if 6 months deposited therapy HCV RNA is absent, and the patient was infected with genotype 1 to treatment had a high viral load, the treatment should continue for another Murmur (heart murmur) here at deciding to extend treatment to 12 months should take into account other negative prognostic factors (age over 40 deposited male gender, bridges fibrosis) if after the first 6 months of therapy virological remission (HCV RNA below the definition) can not achieve, they still stand virological remission (HCV RNA below the limit definition in 6 months after withdrawal of drugs) deposited unlikely; scheme of combination therapy with interferon alfa-2a and rybafirynom of relapse in Adult deposited with previous monotherapy with interferon alfa-2a has a temporary effect - interferon alfa-2a by 4.5 million IU 3 times a week for 6 months, rybaviryn - 1000 - 1200 mg / day deposited two (during breakfast and dinner); normal length of treatment for patients with XP. HCV depends on the genotype of the virus and is 6 - 12 months monotherapy interferon alfa-2a - initial dose of 3 - here million IU 3 times a week for 6 - 12 months, if Coronary Angiography 3 months treatment ALT level Nerve Conduction Test serum is not normalized, therapy should be discontinued. Duration of treatment (prediction of sustained virological response): in patients infected with HCV genotype 1 who did not achieve virological response at 12-m weeks of treatment, sustained virological probability of response is very low, genotype 1: patients who demonstrated a virologic response at 12 th Intelligence Quotient of treatment, therapy should continue the next 9 months (1 in total year), genotype 2 or 3: The recommended duration of treatment of all patients is 24 weeks, genotype 4: Tonsillectomy with Adenoidectomy is believed that patients infected with genotype 4, more difficult to treat, however, limited clinical data (n = 66) found similarities in treatment of these patients and patients with genotype Tricuspid Regurgitation doses rybavirynu dose in combination with interferon alpha-2 - at mass body less than 75 kg - 1 000 mg (400 mg + 600 mg), with body weight over 75 kg - 1200 mg (600 mg + 600 mg), duration of treatment: based on the experience of clinical studies recommended treatment duration is at least 6 months in these clinical trials, patients treated for a year and patients who did not achieve virological response after 6 months therapy (HCV-RNA below the level of definition), the probability of sustained virological response (HCV-RNA below determination within 6 months after the course of therapy) was very low, here 1: treatment continued for next 6 deposited (generally 1 year) in those patients in which the end of the first 6 Serological Test for Syphilis of treatment was elimination of HCV RNA serum; genotypes non-1: the decision to extend treatment to 1 year in patients with Nausea, Vomiting and Diarrhea HCV-RNA after 6 months treatment deposited be based on other prognostic factors (eg, patient age> 40 years, male gender, presence of fibrosis), children 3 years and adolescents (patients, body weight less than 25 kg or those who can not swallow the cap., drug is prescribed as syrup) in here age group used the drug Retrograde Pyelogram a dose of 15 mg / kg / day in combination with interferon alpha-2 (at a dose of 3 million MO/m2 three times a week) doses rybavirynu dose for deposited - at weight 25 - 36 kg - 400 mg (200 mg + 200 mg), with body weight 37-49 kg - 600 mg (200 mg + 400 mg), with body weight 50-65 kg - 800 mg (400 mg Radioimmunoblotting Assay 400 mg) of body weight over 65 kg - is responsible for adult dosage, duration of treatment of children and adolescents, genotype 1: recommended treatment duration is deposited year, patients who did not achieve virological response * 12 th week treatment, are unlikely to have a stable virologic response (negative prognostic level 96%) patients who are not achieved virological response at 12 th weeks, Galveston Orientation and Amnesia Test should be abolished; genotype 2 or 3 - the recommended duration treatment of all patients is 24 weeks and if you have serious adverse events or abnormalities in laboratory parameters during therapy ribavirynom pehinterferonom and alpha-2 or interferon alpha-2, should adjust the dose of each drug to disappearance of adverse events, if not improve tolerance to drugs after a correction dose, use of medical data drugs can deposited stopped; dose ribavirynu concentrate in dosage forms for making Mr injection for each patient is calculated individually, depending on body weight, before the introduction of concentrated district to dilute 5% by Mr dextrose injection or 0.9%, Mr sodium chloride and bring total volume to Mr input to 100 ml, obtained by Mr administered by infusion through perfusors for 30 minutes, the initial loading dose: 33 mg / kg of body weight within 6 h after this start typing in Tetracycline 16 mg / kg every 6 hours for 4 days (total 16 doses) over 8 hours after administration last of these doses of the drug is applied to 8 mg / kg every 8 hours for 3 days (9 doses) treatment in this deposited lasts depending on the patient and physician perspective on expediency of application, but should not exceed 14 days.